Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Verona Pharma PLC
Total Receivables Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Total Receivables
$12.5m
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Total Receivables
ÂŁ7.8B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
4%
AstraZeneca PLC
LSE:AZN
Total Receivables
$12.6B
CAGR 3-Years
23%
CAGR 5-Years
18%
CAGR 10-Years
4%
Indivior PLC
LSE:INDV
Total Receivables
$281m
CAGR 3-Years
16%
CAGR 5-Years
6%
CAGR 10-Years
4%
Hikma Pharmaceuticals PLC
LSE:HIK
Total Receivables
$965m
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
10%
Dechra Pharmaceuticals PLC
LSE:DPH
Total Receivables
ÂŁ176.2m
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
20%

See Also

What is Verona Pharma PLC's Total Receivables?
Total Receivables
12.5m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Total Receivables amounts to 12.5m USD.

What is Verona Pharma PLC's Total Receivables growth rate?
Total Receivables CAGR 5Y
10%

Over the last year, the Total Receivables growth was 31%. The average annual Total Receivables growth rates for Verona Pharma PLC have been 6% over the past three years , 10% over the past five years .

Back to Top